Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure

  1. Moreno-Montañés, J.
  2. Sádaba, B.
  3. Ruz, V.
  4. Gómez-Guiu, A.
  5. Zarranz, J.
  6. González, M.V.
  7. Pañeda, C.
  8. Jimenez, A.I.
Journal:
Molecular Therapy

ISSN: 1525-0024,  1525-0016

Year of publication: 2014

Volume: 22

Issue: 1

Pages: 226-232

Type: Article

DOI: 10.1038/MT.2013.217 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus